122 related articles for article (PubMed ID: 12513713)
21. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)].
Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL
Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524
[TBL] [Abstract][Full Text] [Related]
22. [Effects of c-myc antisense oligodeoxynucleotide on the telomerase activity and the induction of apoptosis in HL-60 cells].
Sun L; Wang F; Sun H; Le XP; Liu LX; Liu YF; Wang F; Wang YH; Ma HY; Zhang QX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):605-9. PubMed ID: 16129043
[TBL] [Abstract][Full Text] [Related]
23. [Effect of antisense oligodeoxynucleotide targeting hTERT on telomerase activity and cell apoptosis in K562 cell line].
Ying XY; Fang MY; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):48-53. PubMed ID: 18315899
[TBL] [Abstract][Full Text] [Related]
24. Effect of antisense hTERT mRNA oligodeoxynucleotide on telomerase activity of leukemic cells.
Zhang Y; He DM
Cell Biol Int; 2002; 26(5):427-31. PubMed ID: 12095228
[TBL] [Abstract][Full Text] [Related]
25. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
Fu XH; Zhang JS; Zhang N; Zhang YD
World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of telomerase with hTERT antisense enhances TNF-alpha-induced apoptosis in prostate cancer cells PC3].
Gao XD; Chen YR
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):723-6. PubMed ID: 17918713
[TBL] [Abstract][Full Text] [Related]
27. Antisense Sp1 oligodeoxynucleotide decreases telomerase activity by inhibiting hTERT mRNA expression in Jurkat T cells.
Pang JX; Cheng XY; Xu W; Wu SG
Acta Pharmacol Sin; 2003 Jan; 24(1):91-6. PubMed ID: 12511235
[TBL] [Abstract][Full Text] [Related]
28. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
29. Real-time quantitative RT-PCR for human telomere elongation reverse transcriptase in chronic myeloid leukemia.
Gil ME; Coetzer TL
Leuk Res; 2004 Sep; 28(9):969-72. PubMed ID: 15234574
[TBL] [Abstract][Full Text] [Related]
30. Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.
Bakalova R; Ohba H; Zhelev Z; Kubo T; Fujii M; Ishikawa M; Shinohara Y; Baba Y
FEBS Lett; 2004 Apr; 564(1-2):73-84. PubMed ID: 15094045
[TBL] [Abstract][Full Text] [Related]
31. [Effect of hTERT ASODN on the oncogenicity and the inductive apoptosis of HL-60 cells].
Sun L; Wang F; Sun H; Le XP; Ge XF; Liu LX; Zhang QX
Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):386-9. PubMed ID: 17147228
[TBL] [Abstract][Full Text] [Related]
32. [Preliminary research on the effect of antisense oligodeoxynucleotides of tankyrase 1 on tumor growth following intratumoral injection in mice].
Zhan ZL; Li C; Sun H
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):604-7. PubMed ID: 15498272
[TBL] [Abstract][Full Text] [Related]
33. A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
Tatematsu K; Nakayama J; Danbara M; Shionoya S; Sato H; Omine M; Ishikawa F
Oncogene; 1996 Nov; 13(10):2265-74. PubMed ID: 8950994
[TBL] [Abstract][Full Text] [Related]
34. [Effects of telomerase sense and antisense oligodeoxynucleotides on growth and differentiation of nasopharyngeal carcinoma cells].
Zhang SZ; Huang PC; Xu Y; Chen J; Cai KR
Ai Zheng; 2002 May; 21(5):493-7. PubMed ID: 12452039
[TBL] [Abstract][Full Text] [Related]
35. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
36. hTERT mRNA levels by real-time RT-PCR in acute myelogenous leukemia.
Huh HJ; Huh JW; Yoo ES; Seong CM; Lee M; Hong KS; Chung WS
Am J Hematol; 2005 Aug; 79(4):267-73. PubMed ID: 16044449
[TBL] [Abstract][Full Text] [Related]
37. Telomerase is limiting the growth of acute myeloid leukemia cells.
Röth A; Vercauteren S; Sutherland HJ; Lansdorp PM
Leukemia; 2003 Dec; 17(12):2410-7. PubMed ID: 14562114
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity in Philadelphia positive chronic myeloid leukaemia.
Rasoul NA; Elhalawani N; Nafae MH; Elkaffash DM; Mourad ZI
Egypt J Immunol; 2004; 11(1):1-8. PubMed ID: 15724380
[TBL] [Abstract][Full Text] [Related]
39. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
Tauchi T; Nakajima A; Sashida G; Shimamoto T; Ohyashiki JH; Abe K; Yamamoto K; Ohyashiki K
Clin Cancer Res; 2002 Nov; 8(11):3341-7. PubMed ID: 12429620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
